Author:
Ludwig H.,Cohen A.M.,Polliack A.,Huber H.,Nachbaur D.,Senn H.-J.,Morant R.,Eckhardt S.,Günczler P.,Seewann H.L.,Schüller J.,Rhyner K.,Cavalli F.,Fritz E.
Reference44 articles.
1. Biochemical pathways in interferon action;Senn;Pharmacol Ther,1984
2. Interactions of human leukocyte interferon with vinca alkaloids and other chemotherapeutic agents against human tumors in clonogenic assay;Aapro;Cancer Chemother Pharmacol,1983
3. Positive interactions between human interferon and cyclophosphamide or adriamycin in a human tumor model system;Balkwill;Cancer Res,1985
4. Human leukocyte interferon and intermittent high-dose melphalan/prednisone administration in the treatment of multiple myeloma: A randomized clinical trial;Ahre;Cancer Treat Rep,1984
5. Recombinant interferon alpha-2c versus polychemotherapy (VMCP) for treatment of multiple myeloma: A prospective randomized trial;Ludwig;Eur J Cancer Clin Oncol,1986
Cited by
86 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献